XNCR 23.72 (+0.38%)
US98401F1057BiotechnologyBiotechnology

Xencor (XNCR) Stock Highlights

23.72 | +0.38%
2024-11-21 03:12:30
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Statistics

Range Today
23.22 23.76
Volume Today 546.6K
Range 1 Year
15.31 26.84
Volume 1 Year 152.24M
Range 3 Year
15.31 42.3
Volume 3 Year 324.68M
Range 10 Year
9.89 58.345
Volume 10 Year 821.41M

Highlights

Market Capitalization 1.65B (small)
Floating Shares 64.02M
Current Price 23.72
Price To Earnings -7.1
Price To Revenue 14.02
Price To Book 2.28
Earnings Per Share -3.24
Payout Ratio 0%

Performance

Latest +0.38%
1 Month +9.87%
3 Months +41.61%
6 Months +3%
1 Year +23.35%
3 Years -36.15%
5 Years -36.31%
10 Years +122.1%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.